Investigation of the Resistome of non- Helicobacter pylori Helicobacter Species.

Microb Drug ResistJul 25, 2026 (epub)

Lucie Bénéjat, Elodie Sifré, Astrid Ducournau et al.

✦ AI-curated · Sources linked

Case in brief

Microbiological analyses were performed on three reported human infections with non–Helicobacter pylori Helicobacter species (NHPH). Because these organisms are difficult to culture, diagnosis relies heavily on histology. 16S rRNA sequencing identified two Helicobacter suis strains and one Helicobacter heilmannii sensu stricto strain. Sequencing of 23S rRNA and the gyrA quinolone resistance-determining region found no mutations classically associated with macrolide or levofloxacin resistance. Several commercial H. pylori assays cross-reacted with the NHPH strains.

What made this case unusual

Commercial assays intended for H. pylori cross-reacted with these NHPH strains, while molecular testing identified the species and found no mutations in the examined resistance-associated regions.

Diagnostic / clinical pearl

Histology-based diagnosis of NHPH infection should be followed by molecular confirmation in a specialized laboratory to identify the species and investigate resistance markers.

Source

Published in Microb Drug Resist. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.